Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2883)
All Articles published online
|
Aug 21, 2009 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL. Anti-microbial antibodies in celiac disease: Trick or treat? World J Gastroenterol 2009; 15(31): 3891-3900 [PMID: 19701969 DOI: 10.3748/wjg.15.3891] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i31/3891.htm |
| Number | Citing Articles |
| 1 |
Boualem Sendid, Christopher Cao, Jean-Frederic Colombel, Daniel Poulain.
Coincidence of antibodies against Hwp1 and ASCA, two distinct molecular targets of
Candida albicans
, reinforces the link between this fungal species and coeliac disease
. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2334085
|
| 2 |
Marion Corouge, Séverine Loridant, Chantal Fradin, Julia Salleron, Sébastien Damiens, Maria Dolores Moragues, Vianney Souplet, Thierry Jouault, Raymond Robert, Sylvain Dubucquoi, Boualem Sendid, Jean Fréderic Colombel, Daniel Poulain, Julian R Naglik. Humoral Immunity Links Candida albicans Infection and Celiac Disease. PLOS ONE 2015; 10(3): e0121776 doi: 10.1371/journal.pone.0121776
|
| 3 |
A. Eser, P. Papay, C. Primas, E. Pernicka, M. Harrer, C. Dejaco, G. Novacek, C. Lichtenberger, S. Angelberger, L. Kazemi, A. Mikulits, H. Vogelsang, W. Reinisch. The impact of intestinal resection on serum levels of anti‐Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 2012; 35(2): 292 doi: 10.1111/j.1365-2036.2011.04932.x
|
| 4 |
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study. Health Technology Assessment 2021; 25(23): 1 doi: 10.3310/hta25230
|
| 5 |
Giulia Gasparini, Emanuele Cozzani, Marzia Caproni, Emiliano Antiga, Alessio Signori, Aurora Parodi. Could anti-glycan antibodies be useful in dermatitis herpetiformis?. European Journal of Dermatology 2019; 29(3): 322 doi: 10.1684/ejd.2019.3542
|
| 6 |
Peter Laszlo Lakatos, Maria Papp, Florian Rieder. Serologic Antiglycan Antibodies in Inflammatory Bowel Disease. American Journal of Gastroenterology 2011; 106(3): 406 doi: 10.1038/ajg.2010.505
|
| 7 |
Lerner Aaron, Matthias Torsten. Candida albicans in celiac disease: A wolf in sheep’s clothing. Autoimmunity Reviews 2020; 19(9): 102621 doi: 10.1016/j.autrev.2020.102621
|
| 8 |
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
|
| 9 |
Tatiana Pochechueva, Francis Jacob, Andre Fedier, Viola Heinzelmann-Schwarz. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches. Metabolites 2012; 2(4): 913 doi: 10.3390/metabo2040913
|
| 10 |
Marco Daperno, Fabiana Castiglione, Lissy de Ridder, Iris Dotan, Martti Färkkilä, Jon Florholmen, Gerald Fraser, Walter Fries, Xavier Hebuterne, Peter Laszlo Lakatos, Julián Panés, Jordi Rimola, Edouard Louis. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2011; 5(5): 484 doi: 10.1016/j.crohns.2011.07.003
|
| 11 |
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos. Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Review of Clinical Immunology 2013; 9(1): 65 doi: 10.1586/eci.12.86
|
| 12 |
Aaron Lerner, Shimon Reif. Infection and Autoimmunity. 2015; : 829 doi: 10.1016/B978-0-444-63269-2.00051-9
|
| 13 |
|
| 14 |
Jason M. Brenchley, Daniel C. Douek. Microbial Translocation Across the GI Tract. Annual Review of Immunology 2012; 30(1): 149 doi: 10.1146/annurev-immunol-020711-075001
|